Phase I study of escalating doses of carfilzomib with HyperCVAD in patients with newly diagnosed acute lymphoblastic leukemia

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)E114-E117
JournalAmerican Journal of Hematology
Volume96
Issue number4
DOIs
StatePublished - Apr 1 2021

ASJC Scopus subject areas

  • Hematology

Cite this